Rare diseases
Investigational molecules
Locations
2 London Wall Place, EC2Y 5AU, United Kingdom
Cyclacel Limited focuses on advanced solid tumors and lymphoma, with clinical activity spanning locally advanced, recurrent, and metastatic disease. Its research includes b-cell lymphoma and t-cell lymphoma, reflecting interest in both solid and blood cancers that have limited treatment options.
The sponsor’s oncology portfolio is centered on patients whose disease has progressed after standard therapies or for whom established treatment options are lacking.
Cyclacel Limited runs clinical trials in conditions such as B-cell lymphoma, Colorectal cancer metastatic, Hepatocellular carcinoma, Breast cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
SpainSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
